These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11597773)

  • 21. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
    Niessen HG; Debska-Vielhaber G; Sander K; Angenstein F; Ludolph AC; Hilfert L; Willker W; Leibfritz D; Heinze HJ; Kunz WS; Vielhaber S
    Eur J Neurosci; 2007 Mar; 25(6):1669-77. PubMed ID: 17432958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
    Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
    J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An astrocyte regenerative response from vimentin-containing cells in the spinal cord of amyotrophic lateral sclerosis's disease-like transgenic (G93A SOD1) mice.
    Zhou Y; Lu Y; Fang X; Zhang J; Li J; Li S; Deng X; Yu Y; Xu R
    Neurodegener Dis; 2015; 15(1):1-12. PubMed ID: 25591625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis.
    Poon HF; Hensley K; Thongboonkerd V; Merchant ML; Lynn BC; Pierce WM; Klein JB; Calabrese V; Butterfield DA
    Free Radic Biol Med; 2005 Aug; 39(4):453-62. PubMed ID: 16043017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parvalbumin and calbindin D-28k immunoreactivity in transgenic mice with a G93A mutant SOD1 gene.
    Sasaki S; Warita H; Komori T; Murakami T; Abe K; Iwata M
    Brain Res; 2006 Apr; 1083(1):196-203. PubMed ID: 16546142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldehyde Dehydrogenases 1A2 Expression and Distribution are Potentially Associated with Neuron Death in Spinal Cord of Tg(SOD1*G93A)1Gur Mice.
    Liang H; Wu C; Deng Y; Zhu L; Zhang J; Gan W; Tang C; Xu R
    Int J Biol Sci; 2017; 13(5):574-587. PubMed ID: 28539831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
    Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
    Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
    Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
    J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
    J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1
    Rodríguez-Cueto C; Santos-García I; García-Toscano L; Espejo-Porras F; Bellido M; Fernández-Ruiz J; Muñoz E; de Lago E
    Biochem Pharmacol; 2018 Nov; 157():217-226. PubMed ID: 30076846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
    Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate release induced by activation of glycine and GABA transporters in spinal cord is enhanced in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Zappettini S; Stigliani S; Paluzzi S; Raiteri M; Bonanno G
    Neurotoxicology; 2005 Oct; 26(5):883-92. PubMed ID: 15885796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
    Cassina P; Pehar M; Vargas MR; Castellanos R; Barbeito AG; Estévez AG; Thompson JA; Beckman JS; Barbeito L
    J Neurochem; 2005 Apr; 93(1):38-46. PubMed ID: 15773903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.
    López-González R; Kunckles P; Velasco I
    Cell Transplant; 2009; 18(10):1171-81. PubMed ID: 19660174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.